Continental Advisors’s ResMed RMD Stock Holding History

Continental Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-7,600	Closed	-$340K	–	141
2014 Q1	$340K	Hold	7,600	–	–	0.09%	118
2013 Q4	$358K	Sell	7,600 -11,400	-60%	-$577K	0.08%	131
2013 Q3	$1M	Buy	19,000 +4,000	+27%	+$194K	0.25%	97
2013 Q2	$677K	Buy	+15,000	New	+$712K	0.19%	96

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Continental Advisors's RMD Position: Q2 2014 in Review

Continental Advisors sold out of ResMed (RMD) in Q2 2014, closing a stake of 7,600 shares — an estimated $340K sold.

Continental Advisors first reported a position in RMD in Q1 2014 and held it in 1 quarter. The position peaked at $340K in Q1 2014. 312 funds tracked by Wall St. Rank hold RMD as of Q2 2014.

Continental Advisors reported no remaining ResMed position as of Q2 2014 after selling out during the quarter.
Continental Advisors sold 7,600 ResMed shares in Q2 2014, an estimated $340K.
Continental Advisors first reported a position in ResMed in Q1 2014 and held it in 1 quarter.
Continental Advisors's ResMed position peaked at $340K in Q1 2014.
312 funds tracked by Wall St. Rank held ResMed as of Q2 2014.

Based on Continental Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.